Nektar Therapeutics - Common Stock (NKTR)

CUSIP: 640268108

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / Common Stock
Shares outstanding
20,788,527
Total 13F shares
133,535,856
Share change
-1,013,589
Total reported value
$2,292,233,354
Put/Call ratio
114%
Price per share
$17.18
Number of holders
189
Value change
-$7,287,187
Number of buys
101
Number of sells
78

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 640268108?
CUSIP 640268108 identifies NKTR - Nektar Therapeutics - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of NKTR - Nektar Therapeutics - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
OppenheimerFunds, Inc.
13F
Company
125%
26,005,353
$370,056,000 30 Jun 2016
13F
PRIMECAP MANAGEMENT CO/CA/
13F
Company
96%
20,002,586
$284,637,000 30 Jun 2016
13F
VANGUARD GROUP INC
13F
Company
56%
11,650,468
$165,787,000 30 Jun 2016
13F
BlackRock Fund Advisors
13F
Company
49%
10,221,478
$145,452,000 30 Jun 2016
13F
Invesco Ltd.
13F
Company
21%
4,322,899
$61,515,000 30 Jun 2016
13F
Camber Capital Management LP
13F
Company
20%
4,250,000
$60,478,000 30 Jun 2016
13F
BRIDGER MANAGEMENT, LLC
13F
Company
17%
3,598,554
$51,207,000 30 Jun 2016
13F
BlackRock Institutional Trust Company, N.A.
13F
Company
16%
3,291,707
$46,841,000 30 Jun 2016
13F
STATE STREET CORP
13F
Company
16%
3,270,484
$46,535,000 30 Jun 2016
13F
RA CAPITAL MANAGEMENT, L.P.
13F
Company
16%
3,224,854
$45,890,000 30 Jun 2016
13F
NORGES BANK
13F
Company
11%
2,301,709
$32,753,000 30 Jun 2016
13F
JANUS HENDERSON INVESTORS US LLC
13F
Company
10%
2,071,804
$29,481,000 30 Jun 2016
13F
Cormorant Asset Management, LP
13F
Company
9.7%
2,022,879
$28,786,000 30 Jun 2016
13F
Granahan Investment Management, LLC
13F
Company
9.5%
1,980,335
$28,180,000 30 Jun 2016
13F
FIRST TRUST ADVISORS LP
13F
Company
9.4%
1,950,931
$27,762,000 30 Jun 2016
13F
FEDERATED HERMES, INC.
13F
Company
8.7%
1,817,803
$25,868,000 30 Jun 2016
13F
Bank of New York Mellon Corp
13F
Company
8.5%
1,768,992
$25,173,000 30 Jun 2016
13F
NORTHERN TRUST CORP
13F
Company
7.6%
1,571,599
$22,363,000 30 Jun 2016
13F
Artal Group S.A.
13F
Company
6.7%
1,400,000
$19,922,000 30 Jun 2016
13F
FMR LLC
13F
Company
6.6%
1,378,903
$19,622,000 30 Jun 2016
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
6.4%
1,336,970
$19,025,000 30 Jun 2016
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
6.1%
1,276,593
$18,165,000 30 Jun 2016
13F
WESTFIELD CAPITAL MANAGEMENT CO LP
13F
Company
5.8%
1,212,050
$17,247,000 30 Jun 2016
13F
Artisan Partners Limited Partnership
13F
Company
4.8%
1,002,832
$14,270,000 30 Jun 2016
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
4.8%
990,835
$14,099,000 30 Jun 2016
13F
RICE HALL JAMES & ASSOCIATES, LLC
13F
Company
4.5%
932,933
$13,276,000 30 Jun 2016
13F
JPMORGAN CHASE & CO
13F
Company
4.2%
873,233
$12,426,000 30 Jun 2016
13F
SYSTEMATIC FINANCIAL MANAGEMENT LP
13F
Company
4%
834,589
$11,876,000 30 Jun 2016
13F
AMERIPRISE FINANCIAL INC
13F
Company
3.2%
658,966
$9,376,000 30 Jun 2016
13F
DEUTSCHE BANK AG\
13F
Company
3.2%
655,066
$9,319,000 30 Jun 2016
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
2.8%
584,500
$8,317,000 30 Jun 2016
13F
BlackRock Investment Management, LLC
13F
Company
2.8%
573,469
$8,160,000 30 Jun 2016
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
2.7%
570,890
$8,124,000 30 Jun 2016
13F
BLACKROCK ADVISORS LLC
13F
Company
2.7%
562,552
$8,005,000 30 Jun 2016
13F
HARVEY CAPITAL MANAGEMENT INC
13F
Company
2.5%
523,100
$7,443,000 30 Jun 2016
13F
ArrowMark Colorado Holdings LLC
13F
Company
2.4%
489,893
$6,971,000 30 Jun 2016
13F
CREDIT SUISSE AG/
13F
Company
2.3%
485,144
$6,903,000 30 Jun 2016
13F
MORGAN STANLEY
13F
Company
2.3%
479,962
$6,829,000 30 Jun 2016
13F
Rhenman & Partners Asset Management AB
13F
Company
2.3%
470,000
$6,688,000 30 Jun 2016
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
2.2%
466,288
$6,636,000 30 Jun 2016
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
2.2%
452,446
$6,438,000 30 Jun 2016
13F
GOLDMAN SACHS GROUP INC
13F
Company
1.9%
394,624
$5,616,000 30 Jun 2016
13F
GUGGENHEIM CAPITAL LLC
13F
Company
1.7%
354,666
$5,047,000 30 Jun 2016
13F
EverPoint Asset Management, LLC
13F
Company
1.7%
350,000
$4,981,000 30 Jun 2016
13F
OXFORD ASSET MANAGEMENT LLP
13F
Company
1.6%
341,794
$4,864,000 30 Jun 2016
13F
PRUDENTIAL FINANCIAL INC
13F
Company
1.6%
328,613
$4,676,000 30 Jun 2016
13F
BLAIR WILLIAM & CO/IL
13F
Company
1.5%
315,129
$4,484,000 30 Jun 2016
13F
S.c.a. Candriam
13F
Individual
1.5%
303,000
$4,312,000 30 Jun 2016
13F
TEACHERS ADVISORS, LLC
13F
Company
1.5%
302,617
$4,306,000 30 Jun 2016
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
1.3%
271,942
$3,870,000 30 Jun 2016
13F

Institutional Holders of Nektar Therapeutics - Common Stock (NKTR) as of Q3 2016

As of 30 Sep 2016, Nektar Therapeutics - Common Stock (NKTR) was held by 189 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 133,535,856 shares. The largest 10 holders included OppenheimerFunds, Inc., PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, BlackRock Fund Advisors, Invesco Ltd., RA CAPITAL MANAGEMENT, LLC, BlackRock Institutional Trust Company, N.A., STATE STREET CORP, CAMBER CAPITAL MANAGEMENT LLC, and BRIDGER MANAGEMENT, LLC. This page lists 189 institutional shareholders reporting positions in this security for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2016 vs Q2 2016 Across Filers

Q2 2016 holders
171
Q3 2016 holders
189
Holder diff
18
Investor Q2 2016 Shares Q3 2016 Shares Share Diff Share Chg % Q2 2016 Value $ Q3 2016 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.